• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous Iron-Induced Hypophosphatemia in Surgical Patients.

作者信息

Richards Toby, Wijaya Linda K, Lim Jayne, Dugan Cory, Dahly Darren

机构信息

School of Health, Sport & Bioscience, University of East London, London, United Kingdom.

Institute of Clinic Trials and Methodology, University College London, London, United Kingdom.

出版信息

JAMA Netw Open. 2025 Apr 1;8(4):e253093. doi: 10.1001/jamanetworkopen.2025.3093.

DOI:10.1001/jamanetworkopen.2025.3093
PMID:40244590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12006868/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/490a/12006868/1c506cea842b/jamanetwopen-e253093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/490a/12006868/1c506cea842b/jamanetwopen-e253093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/490a/12006868/1c506cea842b/jamanetwopen-e253093-g001.jpg

相似文献

1
Intravenous Iron-Induced Hypophosphatemia in Surgical Patients.手术患者静脉补铁所致低磷血症
JAMA Netw Open. 2025 Apr 1;8(4):e253093. doi: 10.1001/jamanetworkopen.2025.3093.
2
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.铁异麦芽糖苷与羧基麦芽糖铁治疗缺铁性贫血低磷血症的效果：两项随机临床试验。
JAMA. 2020 Feb 4;323(5):432-443. doi: 10.1001/jama.2019.22450.
3
Randomized trial of intravenous iron-induced hypophosphatemia.静脉铁诱导低磷血症的随机试验。
JCI Insight. 2018 Dec 6;3(23):124486. doi: 10.1172/jci.insight.124486.
4
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside.铁羧基麦芽糖铁或葡萄糖酸亚铁治疗炎症性肠病患者的低磷血症发生率。
Aliment Pharmacol Ther. 2019 Aug;50(4):397-406. doi: 10.1111/apt.15386. Epub 2019 Jul 2.
5
Hypophosphatemia related to intravenous iron therapy with ferric carboxymaltose: A case series.静脉注射用羧基麦芽糖铁相关性低磷血症：病例系列。
Transfus Med. 2023 Dec;33(6):503-508. doi: 10.1111/tme.12980. Epub 2023 Jun 1.
6
Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery - The DeFICIT trial.择期手术前缺铁或缺铁性贫血患者使用含或不含磷酸取代的羧基麦芽糖铁——DeFICIT试验
J Clin Anesth. 2025 Feb;101:111727. doi: 10.1016/j.jclinane.2024.111727. Epub 2024 Dec 12.
7
Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.高剂量羧基麦芽糖铁和去铁胺麦芽糖铁补充铁后发生低磷血症 - 随机对照 HOMe aFers 研究。
BMC Med. 2020 Jul 13;18(1):178. doi: 10.1186/s12916-020-01643-5.
8
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose.静脉注射羧麦芽糖铁后出现症状性严重低磷血症。
JGH Open. 2019 Mar 27;3(5):438-440. doi: 10.1002/jgh3.12150. eCollection 2019 Oct.
9
Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis.静脉注射铁制剂后低磷血症的比较风险：一项网状Meta分析
Transfus Med Rev. 2020 Jul;34(3):188-194. doi: 10.1016/j.tmrv.2020.07.002. Epub 2020 Jul 23.
10
[Hypophosphatemia following the administration of intravenous iron formulations: A case report and literature review].[静脉注射铁制剂后发生的低磷血症：一例病例报告及文献综述]
Therapie. 2021 Nov-Dec;76(6):705-714. doi: 10.1016/j.therap.2021.04.008. Epub 2021 Apr 21.

引用本文的文献

1
The Effect of Preoperative Intravenous Iron Supplementation on Mortality and Blood Transfusion Requirements in Elderly Patients Undergoing Hip Fracture Surgery: A Prospective Randomized Controlled Trial.术前静脉补铁对老年髋部骨折手术患者死亡率及输血需求的影响：一项前瞻性随机对照试验。
J Clin Med. 2025 Jul 3;14(13):4713. doi: 10.3390/jcm14134713.

本文引用的文献

1
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.铁源性葡聚糖和羧基麦芽糖铁治疗炎症性肠病相关缺铁性贫血患者后出现低磷血症（PHOSPHARE-IBD）：一项随机临床试验。
Gut. 2023 Apr;72(4):644-653. doi: 10.1136/gutjnl-2022-327897. Epub 2022 Sep 9.
2
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.静脉铁治疗后低磷血症：临床发现综合评价及治疗建议。
Bone. 2022 Jan;154:116202. doi: 10.1016/j.bone.2021.116202. Epub 2021 Sep 15.
3
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm study.
未经稀释的羧基麦芽糖铁注射液快速注射治疗缺铁性贫血患者的安全性：一项 II 期单臂研究。
Intern Med J. 2021 Aug;51(8):1304-1311. doi: 10.1111/imj.15195.
4
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.缺铁治疗选择及静脉铁在常规临床实践中应用的问答
Ann Med. 2021 Dec;53(1):274-285. doi: 10.1080/07853890.2020.1867323.
5
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.术前静脉补铁治疗大型腹部手术前贫血（PREVENTT）：一项随机、双盲、对照试验。
Lancet. 2020 Oct 24;396(10259):1353-1361. doi: 10.1016/S0140-6736(20)31539-7. Epub 2020 Sep 5.
6
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.缺铁性贫血及其治疗对女性成纤维细胞生长因子 23 和磷稳态的影响。
J Bone Miner Res. 2013 Aug;28(8):1793-803. doi: 10.1002/jbmr.1923.